Kite Pharma Opens Production Facility In El Segundo, California
06/21/2016
According to company officials, the facility has been designed to produce chimeric antigen receptor (CAR) and T-cell receptor (TCR) product candidates for clinical trials, as well as for the potential launch and commercialization of Kite’s lead CAR T-cell product candidate, KTE-C19, which is in clinical study for the treatment of chemorefractory diffuse large B-cell lymphoma (DLBCL) and other B-cell malignancies. Kite anticipates commercial launch of KTE-C19 in 2017.
The facility is estimated to have the capacity to produce up to 5,000 patient therapies per year. The plant’s location, adjacent to Los Angeles International Airport, is intended to expedite receipt and shipment of engineered T-cells from and to patients across the United States and Europe, a company spokesman said.
“Establishing world-class manufacturing capability has always been a priority for Kite,” said Timothy Moore, Kite’s Executive Vice President of Technical Operations. “Through our continuous efforts to optimize manufacturing, supply chain and quality control, our proprietary process now reduces the time from when a patient’s materials are shipped to our facility to when the engineered T cells are returned to the patient to approximately 14 days, one of the fastest in the industry.”
The El Segundo facility is expected to be operational by the end of this year for clinical production, less than two years after the site groundbreaking in February 2015. The El Segundo facility will complement Kite’s existing clinical manufacturing facilities in Santa Monica, California, that are currently producing therapies for Kite’s ongoing clinical trials.
“We are excited and proud to celebrate the opening of our El Segundo manufacturing facility, the latest milestone in our mission to deliver a potentially transformative therapy to patients with a significant unmet need,” said Arie Belldegrun, M.D., FACS, Kite’s Chairman, President/CEO. “If approved by the FDA, this site will become a model factory serving patients all over the country. We will also continue to innovate and introduce next generation manufacturing technologies at our facility.”
Project Announcements
Titan Mechanical Plans Defiance, Ohio, Fabrication Operations
06/12/2025
Ireland-Based Linde Plans Brownsville, Texas, Operations
06/12/2025
Canadian-Based Torvan Medical Plans High Point, North Carolina, Headquarters-Production Operations
06/12/2025
Amazon Web Services Plans Richmond County, North Carolina, Operations
06/12/2025
Rolls-Royce Expands Mankato, Minnesota, Manufacturing Operations
06/12/2025
StandardAero Component Services Expands Sharonville, Ohio, MRO Operations
06/12/2025
Most Read
-
First Person: Joe Capes, CEO, LiquidStack
Q2 2025
-
The Legal Limits of DEI in Incentives Agreements, Hiring, and Contracting
Q2 2025
-
39th Annual Corporate & 21st Annual Consultants Surveys: What Business Leaders and Consultants Are Saying About Site Selection
Q1 2025
-
Top States for Doing Business in 2024: A Continued Legacy of Excellence
Q3 2024
-
Get Your Mega Site ‘Project Ready’
Q2 2025
-
Why Cold Storage May Defy the Tariff Crunch
Q2 2025
-
Navigating the new era of SCIF construction
Q1 2025